Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Belot

Showing results (191-200 of 250) with videos related to

Pageof 25
Sort By:
The Journal of Experimental Medicine|July 19, 2024
Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupusMarie Jeanpierre, Jade Cognard, Maud Tusseau, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 14, 2015
Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide studyAnne-Sylvia Sacri, Tristan Chambaraud, Bruno Ranchin, et al.
Joint Bone Spine|November 19, 2018
The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritisPhilippe Mertz, Alexandre Belot, Ricard Cervera, et al.
Acta Neuropathologica Communications|July 25, 2015
Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosisGijs Kooij, Rens Braster, Jasper J Koning, et al.
The British Journal of Dermatology|August 16, 2022
COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic responseDidier Bessis, Sophie Trouillet-Assant, Léo-Paul Secco, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 childrenMarie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
Journal of Clinical Immunology|June 7, 2022
DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signalingMaud Tusseau, Ema Lovšin, Charlotte Samaille, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseasesLianne Kearsley-Fleet, Min-Lee Chang, Saskia Lawson-Tovey, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
The Journal of Experimental Medicine|February 19, 2021
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophagesOmmar Omarjee, Anne-Laure Mathieu, Gaëlle Quiniou, et al.
Pageof 25

Showing results (191-200 of 250) with videos related to

Sort By:
Pageof 25
The Journal of Experimental Medicine|July 19, 2024
Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupusMarie Jeanpierre, Jade Cognard, Maud Tusseau, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 14, 2015
Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide studyAnne-Sylvia Sacri, Tristan Chambaraud, Bruno Ranchin, et al.
Joint Bone Spine|November 19, 2018
The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritisPhilippe Mertz, Alexandre Belot, Ricard Cervera, et al.
Acta Neuropathologica Communications|July 25, 2015
Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosisGijs Kooij, Rens Braster, Jasper J Koning, et al.
The British Journal of Dermatology|August 16, 2022
COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic responseDidier Bessis, Sophie Trouillet-Assant, Léo-Paul Secco, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 childrenMarie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
Journal of Clinical Immunology|June 7, 2022
DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signalingMaud Tusseau, Ema Lovšin, Charlotte Samaille, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseasesLianne Kearsley-Fleet, Min-Lee Chang, Saskia Lawson-Tovey, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
The Journal of Experimental Medicine|February 19, 2021
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophagesOmmar Omarjee, Anne-Laure Mathieu, Gaëlle Quiniou, et al.
Pageof 25